HOME >> MEDICINE >> NEWS
Drug not effective in preventing bypass vein clogging

DALLAS-- A new drug, edifoligide, designed to prevent the clogging of veins used in coronary bypass surgery was no more effective than a placebo, according to the results of a Phase III clinical trial led by researchers at Duke Clinical Research Institute (DCRI).

In a coronary artery bypass procedure, surgeons typically remove portions of the saphenous vein from patients' legs and use them as conduits to reroute blood around a blockage in arteries supplying blood to the heart. The most common reason for subsequent failure of the grafts is the progressive narrowing of the vein, which is largely the result of a process known as neointimal hyperplasia.

Since veins are structurally different from arteries, the increased pressure and stress on the implanted vein causes proliferation of smooth muscle within the vessel. Edifoligide, an E2F transcription factor inhibitor, showed an ability in earlier studies to block this cellular proliferation.

"The results of our Phase III trial showed that the edifoligide was absolutely neutral in all endpoints when compared to placebo," said Duke cardiologist John Alexander, M.D., who presented the results of the trial Nov. 13, 2005, at the annual scientific sessions of the American Heart Association. The results of the trial are also being published early and online by the Journal of the American Medical Association.

"Failure of at least one vein graft is quite common within a year of bypass surgery" Alexander said. "While edifoligide had no effect in preventing neointimal hyperplasia, longer-term follow-up and additional research is needed to determine whether the drug has longer-term beneficial effects and to better understand the mechanisms and consequences of vein graft failure."

In response to shear forces and increased pressures in the vein, cells growth increases in the inner lining of the vein. These cells secrete a variety of proteins known as cytokines that modulate the immune response
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
13-Nov-2005


Page: 1 2 3

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. Osteoporosis screening and treatment may be cost-effective for selected older men
3. Study shows radiofrequency ablation highly effective in treating kidney tumors
4. New study examines effectiveness of tailored health messages
5. Scaling up HIV prevention programs is cost effective
6. New study shows Rescue Remedy is an effective all-natural stress, anxiety reliever
7. U of M researchers assess effectiveness of computerized physician order entry system
8. Nepalese researchers identify cost-effective treatment for drug-resistant typhoid
9. Meningitis: effectiveness of preventive vaccination demonstrated
10. U-M study finds lymphoma drug effective over long term
11. Chemotherapy may enhance the effectiveness of brain tumor vaccines

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... ... 31, 2020 , ... Smile Brands Inc., one of the ... States, today announced the grand opening of another affiliated Bright Now! Dental ... convenient hours, a comfortable office, and full-service care at the new Beaumont location. ...
(Date:8/31/2020)... ... August 31, 2020 , ... In an effort to give back ... donating 10 percent of each hotel room booked with a special new rate code ... Northwest Indiana (RMHC-CNI) , effective immediately. Donations will be applied to any room ...
(Date:8/29/2020)... ... 2020 , ... When professor and author Randy Pausch was diagnosed with pancreatic ... Rather than become melancholic, however, he put together a final lecture in Carnegie Hall ... took a negative situation and turned it into something that inspired millions of people ...
(Date:8/28/2020)... ... August 28, 2020 , ... ... subscription to a customized Lighthouse Health & Wellness mobile app and web-portal. NCPCV ... project. Motorola Solutions Foundation awards grants each year to organizations, such as Destination ...
(Date:8/28/2020)... ... August 28, 2020 , ... Ziegler, a specialty investment ... investment in Synchronous Health, a tech-enabled behavioral health and well-being solutions provider. ... empathy with artificial intelligence (AI) to increase access and quality of behavioral health ...
Breaking Medicine News(10 mins):
(Date:8/31/2020)... SEATTLE (PRWEB) , ... August 31, 2020 , ... ... technology research and advisory guide, has named Cloudticity a Gold winner in the ... are industry and peer recogniti o ns from Network Products Guide ...
(Date:8/27/2020)... Pa. (PRWEB) , ... August 27, 2020 , ... ... care coordination software, today announced the successful completion of their 2020 System and ... well as their HITRUST® interim assessment and MARS-E compliance assessment. These achievements reflect ...
(Date:8/27/2020)... ... August 27, 2020 , ... Trella Health, the leading ... provider of cloud CRM, marketing automation, and contact center solutions for senior living ... integration of Trella’s performance intelligence data and insights into Enquire’s CRM solution to ...
Breaking Medicine Technology:
Cached News: